Whole-genome patenting

Gene patenting is now a familiar commercial practice, but there is little awareness that several patents claim ownership of the complete genome sequence of a prokaryote or virus. When these patents are analysed and compared to those for other biological entities, it becomes clear that genome patents...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Malley, Maureen A., Bostanci, Adam, Calvert, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097348/
https://www.ncbi.nlm.nih.gov/pubmed/15883589
http://dx.doi.org/10.1038/nrg1613
_version_ 1783510989598097408
author O'Malley, Maureen A.
Bostanci, Adam
Calvert, Jane
author_facet O'Malley, Maureen A.
Bostanci, Adam
Calvert, Jane
author_sort O'Malley, Maureen A.
collection PubMed
description Gene patenting is now a familiar commercial practice, but there is little awareness that several patents claim ownership of the complete genome sequence of a prokaryote or virus. When these patents are analysed and compared to those for other biological entities, it becomes clear that genome patents seek to exploit the genome as an information base and are part of a broader shift towards intangible intellectual property in genomics.
format Online
Article
Text
id pubmed-7097348
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70973482020-03-26 Whole-genome patenting O'Malley, Maureen A. Bostanci, Adam Calvert, Jane Nat Rev Genet Article Gene patenting is now a familiar commercial practice, but there is little awareness that several patents claim ownership of the complete genome sequence of a prokaryote or virus. When these patents are analysed and compared to those for other biological entities, it becomes clear that genome patents seek to exploit the genome as an information base and are part of a broader shift towards intangible intellectual property in genomics. Nature Publishing Group UK 2005-05-10 2005 /pmc/articles/PMC7097348/ /pubmed/15883589 http://dx.doi.org/10.1038/nrg1613 Text en © Nature Publishing Group 2005 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
O'Malley, Maureen A.
Bostanci, Adam
Calvert, Jane
Whole-genome patenting
title Whole-genome patenting
title_full Whole-genome patenting
title_fullStr Whole-genome patenting
title_full_unstemmed Whole-genome patenting
title_short Whole-genome patenting
title_sort whole-genome patenting
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097348/
https://www.ncbi.nlm.nih.gov/pubmed/15883589
http://dx.doi.org/10.1038/nrg1613
work_keys_str_mv AT omalleymaureena wholegenomepatenting
AT bostanciadam wholegenomepatenting
AT calvertjane wholegenomepatenting

Ejemplares similares